ETB115E2201: A phase II, open-label, non-controlled, intra-patient dose escalation study to characterize the pharmacokinetics after oral administration of eltrombopag in pediatric patients with refractory, relapsed or treatment

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/1812/31/24

Funding

  • Novartis Pharmaceuticals Corporation